These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 6770965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 3. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Eur J Pharmacol; 1980 May 02; 63(2-3):217-22. PubMed ID: 6155277
    [Abstract] [Full Text] [Related]

  • 4. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

  • 5. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH, Dvorkin B, Klein PN.
    Proc Natl Acad Sci U S A; 1982 Jul 16; 79(13):4212-6. PubMed ID: 6213964
    [Abstract] [Full Text] [Related]

  • 6. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ, Wreggett KA, Seeman P.
    J Neurosci; 1982 Jul 16; 2(7):895-906. PubMed ID: 6124583
    [Abstract] [Full Text] [Related]

  • 7. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA, Altar CA, Wong CA, Marshall JF.
    Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705
    [Abstract] [Full Text] [Related]

  • 8. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P, Woodruff GN, Poat JA.
    Eur J Pharmacol; 1979 Apr 15; 55(2):137-42. PubMed ID: 456412
    [Abstract] [Full Text] [Related]

  • 9. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 10. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 09; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR, Watanabe M, Seeman P.
    J Neurochem; 1985 Apr 09; 44(4):1168-77. PubMed ID: 2579204
    [Abstract] [Full Text] [Related]

  • 12. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW, Leff SE, Creese I.
    Biochem Pharmacol; 1984 Mar 15; 33(6):877-87. PubMed ID: 6712712
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE, Ciaranello RD.
    Proc Natl Acad Sci U S A; 1981 May 15; 78(5):3255-9. PubMed ID: 6166945
    [Abstract] [Full Text] [Related]

  • 14. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W, De Blasi A.
    Pol J Pharmacol Pharm; 1983 May 15; 35(1):45-7. PubMed ID: 6889186
    [Abstract] [Full Text] [Related]

  • 15. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA, Mahler HR.
    Neurochem Res; 1982 Jul 15; 7(7):831-7. PubMed ID: 7121724
    [Abstract] [Full Text] [Related]

  • 16. Species variation in dopamine receptor binding.
    Creese I, Stewart K, Snyder SH.
    Eur J Pharmacol; 1979 Nov 23; 60(1):55-66. PubMed ID: 520417
    [Abstract] [Full Text] [Related]

  • 17. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ, Costall B, Naylor RJ.
    J Pharm Pharmacol; 1983 Nov 23; 35(11):738-45. PubMed ID: 6139456
    [Abstract] [Full Text] [Related]

  • 18. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN.
    Cell Mol Neurobiol; 1981 Jun 23; 1(2):167-74. PubMed ID: 7346167
    [Abstract] [Full Text] [Related]

  • 19. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA, Finch CE.
    Brain Res; 1980 Jun 16; 192(1):147-62. PubMed ID: 6155174
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ, Iversen LL.
    J Neurochem; 1981 Nov 16; 37(5):1130-43. PubMed ID: 7299392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.